WindRose Health Investors, a healthcare-focused PE firm, announced that its portfolio company, Healthmap Solutions, raised $100 million to support the ongoing expansion of its business. Healthmap is a national population health management company focused on kidney disease. The company is contracted with its health plan customers to serve over 160,000 individuals.
Today, Healthmap is contracted to manage over $3 billion in healthcare spend through risk-based arrangements with a number of the country’s health plans and at-risk providers. WindRose financed the transaction, which included commitments from WindRose’s sixth fund as well as a new WindRose vehicle capitalized and led by StepStone Group and joined by other new and existing investors. Read more.
